This is the authors' abstract. We don't add key points for this paper.
Introduction: mutation testing in the German outpatient oncology setting. Methods: Office-based oncologists completed a 23-item online survey. Responses were evaluated collectively and by center type. Results: mutation testing for targeted treatment selection as good to satisfactory; 22% rated awareness as poor to in-sufficient. Conclusion: mutation-related cancer(s).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lux et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: